Literature DB >> 9531275

Differential susceptibility to activation-induced apoptosis among peripheral Th1 subsets: correlation with Bcl-2 expression and consequences for AIDS pathogenesis.

E Ledru1, H Lecoeur, S Garcia, T Debord, M L Gougeon.   

Abstract

It has been proposed that HIV infection is associated with an imbalance in Th1 and Th2 subsets. Recent reports indicate that Th1 and Th2 effectors differ in their susceptibility to activation-induced apoptosis. To determine whether increased T cell apoptosis in HIV-infected patients contributes to alterations in cytokine synthesis, we performed single-cell analysis of type 1 and type 2 cytokine production by CD4 and CD8 T cells, simultaneously with detection of apoptosis. We demonstrate that a differential alteration in representation of Th1 subsets, rather than commitment of T cells to secrete Th2 cytokines, occurs throughout HIV infection. A significant decrease in the number of IL-2- or TNF-alpha-producing T cells was observed, whereas those producing IFN-gamma remained preserved. Furthermore, there is a gradient of susceptibility to activation-induced apoptosis (IL-2 < IFN-gamma < TNF-alpha) among the different Th1 subsets. This gradient was detected in both CD4 and CD8 subsets, as well as in control donors and HIV-infected patients, in whom the susceptibility to apoptosis of IL-2 and IFN-gamma producers was increased compared with controls. This differential intrinsic apoptosis susceptibility of Th1 effectors was found to be tightly regulated by Bcl-2 expression. In HIV-infected persons, disappearance of IL-2-producing T cells was a good indicator of disease progression and was correlated with the progressive shrinkage of the CD4+ CD45RA+ T cell compartment and a gradual increased susceptibility to activation-induced apoptosis of the IL-2-producing subset. This close relationship between the CD45RA/CD45R0 ratio, the level of type 1 cytokine production, and susceptibility to apoptosis should be considered in HIV-infected patients under antiviral or immune-based therapies.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9531275

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  26 in total

1.  Is ageing associated with a shift in the balance between Type 1 and Type 2 cytokines in humans?

Authors:  M Sandmand; H Bruunsgaard; K Kemp; K Andersen-Ranberg; A N Pedersen; P Skinhøj; B K Pedersen
Journal:  Clin Exp Immunol       Date:  2002-01       Impact factor: 4.330

2.  T cell responses to highly active antiretroviral therapy defined by chemokine receptors expression, cytokine production, T cell receptor repertoire and anti-HIV T-lymphocyte activity.

Authors:  A Giovannetti; M Pierdominici; F Mazzetta; S Salemi; M Marziali; D Kuonen; F Iebba; E A Lusi; A Cossarizza; F Aiuti
Journal:  Clin Exp Immunol       Date:  2001-04       Impact factor: 4.330

3.  HIV-1 envelope induces activation of caspase-3 and cleavage of focal adhesion kinase in primary human CD4(+) T cells.

Authors:  C Cicala; J Arthos; A Rubbert; S Selig; K Wildt; O J Cohen; A S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-01       Impact factor: 11.205

4.  Secretion modification region-derived peptide disrupts HIV-1 Nef's interaction with mortalin and blocks virus and Nef exosome release.

Authors:  Martin N Shelton; Ming-Bo Huang; Syed A Ali; Michael D Powell; Vincent C Bond
Journal:  J Virol       Date:  2011-10-19       Impact factor: 5.103

5.  Death-inducing receptors and apoptotic changes in lymphocytes of patients with heart transplant vasculopathy.

Authors:  H J Ankersmit; B Moser; S Roedler; I Teufel; A Zuckermann; G Roth; K Lietz; C Back; S Gerlitz; E Wolner; G Boltz-Nitulescu
Journal:  Clin Exp Immunol       Date:  2002-01       Impact factor: 4.330

6.  Effects of orally administered viable Lactobacillus rhamnosus GG and Propionibacterium freudenreichii subsp. shermanii JS on mouse lymphocyte proliferation.

Authors:  P V Kirjavainen; H S ElNezami; S J Salminen; J T Ahokas; P F Wright
Journal:  Clin Diagn Lab Immunol       Date:  1999-11

7.  Mechanisms of apoptosis of T-cells in human tuberculosis.

Authors:  Christina S Hirsch; John L Johnson; Alphonse Okwera; Richard A Kanost; Mianda Wu; Pierre Peters; Mathew Muhumuza; Harriet Mayanja-Kizza; Roy D Mugerwa; Peter Mugyenyi; Jerrold J Ellner; Zahra Toossi
Journal:  J Clin Immunol       Date:  2005-07       Impact factor: 8.317

8.  TH1 and TH2 cytokine mRNA and protein levels in human immunodeficiency virus (HIV)-seropositive and HIV-seronegative youths.

Authors:  Steven D Douglas; Stephen Durako; Kathleen E Sullivan; Margaret Camarca; Anna-Barbara Moscicki; Craig M Wilson
Journal:  Clin Diagn Lab Immunol       Date:  2003-05

9.  Effect of TNF-alpha genetic variants and CCR5 Delta 32 on the vulnerability to HIV-1 infection and disease progression in Caucasian Spaniards.

Authors:  Sergi Veloso; Montserrat Olona; Felipe García; Pere Domingo; Carlos Alonso-Villaverde; Montserrat Broch; Joaquim Peraire; Consuelo Viladés; Montserrat Plana; Enric Pedrol; Miguel López-Dupla; Carmen Aguilar; Mar Gutiérrez; Agathe Leon; Mariona Tasias; Josep Ma Gatell; Cristóbal Richart; Francesc Vidal
Journal:  BMC Med Genet       Date:  2010-04-26       Impact factor: 2.103

10.  DC expressing transgene Foxp3 are regulatory APC.

Authors:  Michael W Lipscomb; Jennifer L Taylor; Cristina J Goldbach; Simon C Watkins; Amy K Wesa; Walter J Storkus
Journal:  Eur J Immunol       Date:  2010-02       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.